Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 22Parasitic Diseases Research and TreatmentResearch on Leishmaniasis StudiesMalaria Research and Control

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Efficacy of High-Dose Albendazole with Ivermectin for Treating Imported Loiasis, Italy

Open access

Abstract

We describe the outcomes of 16 cases of imported loiasis in Italy. Patients had microfilaremia <20,000/mL and were treated with high-dose albendazole for 28 days and a single dose of ivermectin. This combination might be an effective treatment option in nonendemic areas, when diethylcarbamazine, the drug of choice, is not available.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3201/eid2508.190011

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 22

Metadata

Authors
Gobbi, F., Buonfrate, D., Tamarozzi, F., Degani, M., Angheben, A., & Bisoffi, Z.
Affiliations
University of Verona (IT)
Corresponding author
Gobbi, Federico
Venue
Emerging Infectious Diseases
Published
2019-08
Volume
25
Issue
8
Pages
1574-1576
ISSN
  • 1080-6040 (ISSN-L)
  • 1080-6059
OpenAlex
W2955219357
Cited by
21
References
16
Citations by year
2025: 6 · 2024: 2 · 2023: 5 · 2022: 2 · 2021: 4 · 2020: 2
FWCI
1.53
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Emerging infectious diseases (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Ministero della Salute
Topics
  • Health Sciences › Medicine › Infectious Diseases › Parasitic Diseases Research and Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Research on Leishmaniasis Studies
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
Keywords
loiasis, imported parasitic infection, albendazole, ivermectin, combination chemotherapy, microfilaremia, non-endemic region
MeSH terms
Communicable Diseases, Imported, Adolescent, Adult, Aged, Antiprotozoal Agents, Drug Therapy, Combination, Enzyme-Linked Immunosorbent Assay, Female, Humans, Italy, Ivermectin, Loiasis, Male, Middle Aged, Biomarkers, Albendazole, Treatment Outcome, Young Adult, Symptom Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.